BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38200443)

  • 41. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
    Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
    Geng Q; Li Z; Li X; Wu Y; Chen N
    J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
    Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
    BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Hu C; Zhou A; Hu X; Xiang Y; Huang M; Huang J; Yang D; Tang Y
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate.
    Cho JH; Hong WG; Jung YJ; Lee J; Lee E; Hwang SG; Um HD; Park JK
    Tumour Biol; 2016 Jun; 37(6):7315-25. PubMed ID: 26671552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways.
    Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X
    Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer.
    Zhang JX; Zhai JF; Yang XT; Wang J
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3793-3801. PubMed ID: 27735039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
    Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
    Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circular RNA hsa_circ_0000554 promotes progression and elevates radioresistance through the miR-485-5p/fermitin family members 1 axis in esophageal cancer.
    Wang J; Chen Y; Wu R; Lin Y
    Anticancer Drugs; 2021 Apr; 32(4):405-416. PubMed ID: 33470617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Centromere protein U promotes cell proliferation, migration and invasion involving Wnt/β-catenin signaling pathway in non-small cell lung cancer.
    Zhang Q; Li YD; Zhang SX; Shi YY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7768-7777. PubMed ID: 30536323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
    Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
    J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer.
    Li JM; Yang F; Li J; Yuan WQ; Wang H; Luo YQ
    Med Sci Monit; 2020 Aug; 26():e925298. PubMed ID: 32764530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC.
    Zhou F; Geng J; Xu S; Meng Q; Chen K; Liu F; Yang F; Pan B; Yu Y
    Aging (Albany NY); 2019 Aug; 11(16):6069-6088. PubMed ID: 31444970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.